Evidence map›Paper›PMID 26574480›Full record

ArticleClinical science (London, England : 1979)2016

Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effector.

Jing Xu, Pei-Xue Li, Jun Wu, Yi-Jun Gao, Meng-Xin Yin, Ye Lin, Ming Yang, Dong-Ping Chen, Hai-Peng Sun, Zeng-Bo Liu and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical science (London, England : 1979), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Effect of Inactivation ofJournal of the Endocrine Society · 2022
    Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 2 countries.

Jing XuDivision of Nephrology, Kidney Institute of CPLA, Changzheng Hospital, Second Military Medical University, 415 Feng Yang Road, Shanghai 200003, P.R. China.
Pei-Xue LiState Key Laboratory of Cell Biology, Innovation Center for Cell Signaling Network, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue-Yang Road, Shanghai 200031, P.R. China.
Jun WuDivision of Nephrology, Kidney Institute of CPLA, Changzheng Hospital, Second Military Medical University, 415 Feng Yang Road, Shanghai 200003, P.R. China.
Yi-Jun GaoMemorial Sloan Kettering Cancer Center, New York, NY 10065, U.S.A.
Meng-Xin YinState Key Laboratory of Cell Biology, Innovation Center for Cell Signaling Network, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue-Yang Road, Shanghai 200031, P.R. China.
Ye LinDivision of Nephrology, Kidney Institute of CPLA, Changzheng Hospital, Second Military Medical University, 415 Feng Yang Road, Shanghai 200003, P.R. China.
Ming YangDivision of Nephrology, Kidney Institute of CPLA, Changzheng Hospital, Second Military Medical University, 415 Feng Yang Road, Shanghai 200003, P.R. China.
Dong-Ping ChenDivision of Nephrology, Kidney Institute of CPLA, Changzheng Hospital, Second Military Medical University, 415 Feng Yang Road, Shanghai 200003, P.R. China.
Hai-Peng SunDivision of Nephrology, Central Hospital of TaiAn, TaiAn, Shandong 271000, P.R. China.
Zeng-Bo LiuDivision of Nephrology, No. 456 Hospital of PLA, Jinan, Shandong 250031, P.R. China.
Xiang-Chen GuDivision of Nephrology, Yueyang Hospital, Shanghai 200437, P.R. China.
Hong-Ling HuangLaboratory of Angiogenesis and Neurovascular link, Vesalius Research Center, VIB, Leuven, B-3000, Belgium.
Li-Li FuDivision of Nephrology, Kidney Institute of CPLA, Changzheng Hospital, Second Military Medical University, 415 Feng Yang Road, Shanghai 200003, P.R. China.
Hui-Min HuDivision of Nephrology, Kidney Institute of CPLA, Changzheng Hospital, Second Military Medical University, 415 Feng Yang Road, Shanghai 200003, P.R. China.
Liang-Liang HeDivision of Nephrology, Kidney Institute of CPLA, Changzheng Hospital, Second Military Medical University, 415 Feng Yang Road, Shanghai 200003, P.R. China.
Wen-Qing WuState Key Laboratory of Cell Biology, Innovation Center for Cell Signaling Network, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue-Yang Road, Shanghai 200031, P.R. China.
Zhao-Liang FeiState Key Laboratory of Cell Biology, Innovation Center for Cell Signaling Network, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue-Yang Road, Shanghai 200031, P.R. China.
Hong-Bin JiState Key Laboratory of Cell Biology, Innovation Center for Cell Signaling Network, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue-Yang Road, Shanghai 200031, P.R. China.
Lei ZhangState Key Laboratory of Cell Biology, Innovation Center for Cell Signaling Network, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue-Yang Road, Shanghai 200031, P.R. China chlmei1954@126.com rayzhang@sibcb.ac.cn.
Chang-Lin MeiDivision of Nephrology, Kidney Institute of CPLA, Changzheng Hospital, Second Military Medical University, 415 Feng Yang Road, Shanghai 200003, P.R. China chlmei1954@126.com rayzhang@sibcb.ac.cn.
Second Military Medical University · CNCenter for Excellence in Molecular Cell Science · CNChinese Academy of Sciences · CNPeople's Liberation Army 401 Hospital · CNShanghai Institutes for Biological Sciences · CNTaian City Central Hospital · CNVIB-KU Leuven Center for Cancer Biology · BEYueyang Hospital · CN

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Renal tubule cells can recover after they undergo AKI (acute kidney injury). An incomplete repair of renal tubules can result in progressive fibrotic CKD (chronic kidney disease). Studies have revealed the relationship between tubular epithelial cells and kidney fibrogenesis. However, the underlying mechanism remains unclear. Hippo pathway components were evaluated in complete/incomplete repair of I/R (ischaemia/reperfusion) AKI rat models, HK-2 cells and AKI human renal biopsy samples. We found that the expression levels of the Hippo pathway components changed dynamically during kidney regeneration and fibrogenesis in rat models of I/R-induced AKI and human renal biopsy samples. The transcription cofactor YAP (Yes-associated protein) might be a key effector of renal regeneration and fibrogenesis. Our results showed further that YAP might elicit both beneficial and detrimental effects on I/R AKI. After I/R injury occurred, YAP could promote the repair of the injured epithelia. The constant YAP increase and activation might be related to interstitial fibrosis and abnormal renal tubule differentiation. These results indicate that the proper modulation of the Hippo pathway, specifically the transcription cofactor YAP, during repair might be a potent therapeutic target in AKI-CKD transition after I/R injury.

Indexed as

Acute Kidney InjuryAdaptor Proteins, Signal TransducingAdolescentAdultAgedAnimalsApoptosis Regulatory ProteinsCell DifferentiationCell ProliferationCells, CulturedDigitoxinFemaleFibrosisGene Knockdown TechniquesHepatocyte Growth FactorHumansAdaptor Proteins, Signal TransducingApoptosis Regulatory ProteinsDigitoxinHepatocyte Growth FactorLats1 protein, ratmacrophage stimulating proteinPhosphoproteinsProtein Serine-Threonine KinasesProto-Oncogene ProteinsTranscription FactorsYAP1 protein, humanYap1 protein, ratYAP-Signaling Proteinsacute kidney injurychronic kidney diseasefibrogenesisHippo pathwayrepairYes-associated protein (YAP)

Identifiers

PMID26574480
PMCPMC4727597
OpenAlexW2278508017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.